Miranda Worley
Medical · Yanceyville, NCNPI 1093041865
Payments from drug & device makers
Across 133 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$299
- Supernus Pharmaceuticals, Inc.$293
- Novo Nordisk$175
- Pfizer$166
- Amgen$152
- GSK$126
- plus $1K from 29 others
What the payments were for
- Food & beverage$2,338100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 19 | $299 |
| Supernus Pharmaceuticals, Inc. | 7 | $293 |
| Novo Nordisk | 12 | $175 |
| Pfizer | 11 | $166 |
| Amgen | 10 | $152 |
| GSK | 9 | $126 |
| Sanofi-aventis U.S. LLC | 6 | $124 |
| Exact Sciences | 7 | $115 |
| AstraZeneca | 6 | $95 |
| Abbott | 3 | $69 |
| Novartis | 4 | $68 |
| Boehringer Ingelheim | 4 | $66 |
| Astellas Pharma US Inc | 4 | $54 |
| Merck | 4 | $54 |
| Eisai Inc. | 3 | $45 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $43 |
| Biohaven Pharmaceuticals, Inc. | 2 | $38 |
| Hologic Sales And Service, LLC | 2 | $34 |
| AbbVie | 2 | $34 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Viatris Specialty LLC | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $21 |
| Medtronic | 1 | $19 |
| Axonics, Inc. | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| ANI Pharmaceuticals, Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Avion Pharmaceuticals | 1 | $15 |
| Shield Therapeutics Inc | 1 | $13 |
| Bayer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$202
How this compares
$2,338 in reported general payments places this provider in the 75th percentile of 878 medical providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 23 | $31,640 |
| MounjaroTirzepatide | 18 | $19,747 |
| EliquisApixaban | 21 | $17,706 |
| LinzessLinaclotide | 23 | $16,208 |
| MyrbetriqMirabegron | 19 | $13,064 |
| JardianceEmpagliflozin | 11 | $12,449 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $7,484 |
| Incruse ElliptaUmeclidinium Bromide | 12 | $4,279 |
| Gabapentin | 116 | $1,660 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $1,375 |
| SynthroidLevothyroxine Sodium | 13 | $1,269 |
| Diclofenac Sodium | 20 | $999 |
| Omeprazole | 98 | $961 |
| Rosuvastatin Calcium | 73 | $781 |
| Levothyroxine Sodium | 110 | $654 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $175 | $31,64023 claims |
| Lilly USA, LLCMounjaro | $299 | $19,74718 claims |
| PfizerEliquis | $166 | $17,70621 claims |
| AbbVieLinzess, Synthroid | $34 | $17,47736 claims |
| Astellas Pharma US IncMyrbetriq | $54 | $13,06419 claims |
| Boehringer IngelheimJardiance | $66 | $12,44911 claims |
| GSKIncruse Ellipta | $126 | $4,27912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 878 medical providers in North Carolina.
Other medical in Yanceyville
- Grace McLaurinHickory$553K
- Joel ThompsonCharlotte$269K
- Virginia JethroCary$213K
- Payal Soni-PatelAsheville$76K
- William JarrettElkin$59K
- Amanda ZimmermanWinston Salem$48K
- David TaylorMorehead City$40K
- Katherine CardSalisbury$39K
- John RobbinsWinston Salem$26K
- Ashley TipperStatesville$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.